Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 16269584)

Published in Am J Epidemiol on November 03, 2005

Authors

Lisa M Bodnar1, Roberta B Ness, Gail F Harger, James M Roberts

Author Affiliations

1: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. Bodnar@edc.pitt.edu

Articles citing this

Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36

Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol (2013) 1.75

Epidemiology of preeclampsia: impact of obesity. Nutr Rev (2013) 0.97

C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension (2008) 0.90

Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol (2015) 0.86

Obese melanocortin-4 receptor-deficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Rep (2013) 0.84

Overweight and Obesity before, during and after Pregnancy: Part 1: Pathophysiology, Molecular Biology and Epigenetic Consequences. Geburtshilfe Frauenheilkd (2014) 0.83

A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia. Hypertens Pregnancy (2008) 0.82

Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am J Obstet Gynecol (2016) 0.79

Role of dyslipidemia in preeclamptic overweight pregnant women. Iran J Reprod Med (2012) 0.79

Risk factors differ between recurrent and incident preeclampsia: a hospital-based cohort study. Ann Epidemiol (2014) 0.79

Does C-reactive protein predict recurrent preeclampsia? Hypertens Pregnancy (2010) 0.77

Is there evidence of separate inflammatory or metabolic forms of preeclampsia? Hypertens Pregnancy (2010) 0.77

A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76

Metabolic syndrome in preeclampsia women in gorgan. Open Biochem J (2014) 0.75

The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial. BMC Med (2017) 0.75

Pre-Pregnancy Body Mass Index Is Associated with Dietary Inflammatory Index and C-Reactive Protein Concentrations during Pregnancy. Nutrients (2017) 0.75

Associations Among Child Abuse, Depression, and Interleukin-6 in Pregnant Adolescents: Paradoxical Findings. Psychosom Med (2016) 0.75

Articles by these authors

Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol (2003) 7.02

Living with or without cyclins and cyclin-dependent kinases. Genes Dev (2004) 6.54

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11

CDK inhibitors: cell cycle regulators and beyond. Dev Cell (2008) 5.07

High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr (2007) 4.61

Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16

Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell (2003) 3.91

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86

A new description of cellular quiescence. PLoS Biol (2006) 3.56

Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol (2013) 3.46

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42

Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med (2005) 3.31

Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol (2009) 3.18

p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev (2004) 3.16

Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis (2010) 3.15

Kinase-independent function of cyclin E. Mol Cell (2007) 3.03

Saving the National Children's Study. Epidemiology (2010) 3.02

Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev (2007) 3.00

p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev (2006) 2.89

Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension (2005) 2.58

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40

Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell (2007) 2.38

Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA (2002) 2.36

Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science (2008) 2.29

Subclassification of preeclampsia. Hypertens Pregnancy (2003) 2.25

Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol (2007) 2.14

The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol (2005) 2.12

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09

A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev (2006) 2.05

Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol (2002) 2.04

Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat Rev Cancer (2004) 1.99

Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92

Preventing and treating eclamptic seizures. BMJ (2002) 1.88

Depression, stress, and social support as predictors of high-risk sexual behaviors and STIs in young women. J Adolesc Health (2006) 1.84

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst (2006) 1.74

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73

Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol (2006) 1.70

Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect (2007) 1.70

Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68

National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Ann Intern Med (2010) 1.67

First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol (2012) 1.66

Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis (2004) 1.65

Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr (2010) 1.64

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol (2004) 1.62

Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab (2005) 1.61

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. Gynecol Oncol (2002) 1.60

A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell (2005) 1.59

Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology (2007) 1.58

A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig (2002) 1.57

Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet Gynecol (2003) 1.57

Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol (2007) 1.57

Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension (2007) 1.56

Quality of life utilities for pelvic inflammatory disease health states. Sex Transm Dis (2008) 1.54

Race Disparities and Decreasing Birth Weight: Are All Babies Getting Smaller? Am J Epidemiol (2015) 1.53

Racial differences in perception of healthy body weight in midlife women: results from the Do Stage Transitions Result in Detectable Effects study. Menopause (2013) 1.49

Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clin Infect Dis (2007) 1.47

Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47

N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). Mol Cell (2004) 1.45

Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obstet Gynecol (2008) 1.45

First trimester exposure to ambient air pollution, pregnancy complications and adverse birth outcomes in Allegheny County, PA. Matern Child Health J (2013) 1.44

Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet (2009) 1.42

Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci (2007) 1.42

Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol (2007) 1.40

Lipid-lowering drug use and breast cancer in older women: a prospective study. J Womens Health (Larchmt) (2003) 1.39

Fear of failure: why american science is not winning the war on cancer. Ann Epidemiol (2010) 1.38

Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates. J Nutr (2007) 1.37

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36

Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol (2004) 1.35

Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol (2006) 1.34

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab (2004) 1.34

Accuracy and reliability of maternal recall of infant birth weight among older women. Ann Epidemiol (2005) 1.33

Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol (2004) 1.30

NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements (2010) 1.30

Redefining preeclampsia using placenta-derived biomarkers. Hypertension (2013) 1.30

Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol (2007) 1.29

Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J Clin Invest (2009) 1.28

Counterpoint: the future of innovative epidemiology. Am J Epidemiol (2013) 1.27

The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol (2003) 1.26

Strategy for standardization of preeclampsia research study design. Hypertension (2014) 1.25

Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev (2008) 1.25

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev (2013) 1.22

Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study. J Clin Endocrinol Metab (2010) 1.22

Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens (2008) 1.22